. home.aspx



Merck, Pfizer keep high-flying vaccine sales intact with key CDC backing

June 27, 2019 / Eric Sagonowsky

Merck and Pfizer faced uncertainty on big-selling vaccines going into this week meeting of the Advisory Committee on Immunization Practices, a CDC panel that sets U.S. vaccination policy. But in votes on Wednesday, the panel either maintained favourable recommendations for the vaccines, or in Merck’s case, expanded recommendations. ACIP expanded its recommendation for Merck’s HPV vaccine Gardasil 9 to men and women aged 27 through 45 who aren’t adequately vaccinated. The panel had already recommended the shot for people up to age 26. In a note to clients, Cantor Fitzgerald analyst Louise Chen wrote that the vaccine has shown the best efficacy in younger people, and ACIP worried that an expanded recommendation “might draw vaccine supply away from young children and teenagers.”  “However, the working group believes the safety profile and cancer prevention effectiveness outweigh the supply and demand issues,” she added. Gardasil has been a re...